0160 Buy — Msdc

In clinical trials, MSDC-0160 has been reported as generally well-tolerated.

Note: Prices are based on MedChemExpress data and are subject to change.

Clinical proof-of-concept study with MSDC-0160, a ... - PubMed msdc 0160 buy

: Successfully completed Phase 2b trials where it lowered HbA1c levels similarly to pioglitazone (Actos) but with 50% less fluid retention.

While researchers and companies often list it for sale online, it is critical to note that for human use outside of clinical trials. Product Overview In clinical trials, MSDC-0160 has been reported as

(also known as Mitoglitazone) is an investigational drug originally developed to treat Type 2 diabetes. It is currently being explored for its potential to treat neurodegenerative diseases like Parkinson’s and Alzheimer’s.

: You can find listings for high-purity (often 99%+) research-grade MSDC-0160 at specialized suppliers like MedChemExpress and Selleck Chemicals . Sample Pricing : 2 mg : ~$55 USD 10 mg : ~$132 USD 50 mg : ~$275 USD - PubMed : Successfully completed Phase 2b trials

: It is a first-in-class "mTOT Modulator" that works by inhibiting the mitochondrial pyruvate carrier (MPC). Unlike older diabetes drugs, it is "PPARγ-sparing," meaning it aims to provide the same glucose-lowering benefits with fewer side effects like weight gain or fluid retention. Current Research Status :